Movano health reports 2023 financial results and provides business update

Executes $24 million funding extending cash runway  focuses on 2024 strategic pathway to fda clearances driving b2b opportunities  plans launch of evie med  conference call at 2:00 pm pt/ 5:00 pm et today pleasanton, calif. , april 4, 2024 /prnewswire/ -- movano health (nasdaq: move), a pioneer in health technology, reported fourth quarter and year end 2023 results and provided a business update.
MOVE Ratings Summary
MOVE Quant Ranking